Skip to content

Clinical Study of Jianpi Yangfei Decoction Combined with Active Breathing and Circulation Technique (ACBT) Training in Treating Elderly Pulmonary Infection

Clinical Study of Jianpi Yangfei Decoction Combined with Active Breathing and Circulation Technique (ACBT) Training in Treating Elderly Pulmonary Infection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047841
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-11-11
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly lung infections

Interventions

Sponsors

Lishui Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria of Western medicine refer to "Internal Medicine": those with fever; those with white blood cell count (WBC) > 10 x 10^9 cells/L; 2. Those with aggravated symptoms of the original respiratory disease or with severe cough and expectoration; those with purulent sputum; 3. Chest X or CT examination showing signs of pulmonary consolidation and pulmonary wet rales; 4. The TCM diagnostic criteria refer to "Traditional Chinese Medicine Disease Syndrome Diagnosis and Efficacy Criteria": thick phlegm with yellow color, phlegm in the throat, strong heat and irritability, shortness of breath, suffocation, etc.; 5. Voluntarily sign the informed consent; meet the diagnostic criteria for pulmonary infection; 6. Age > 60 years old; 7. The patient can be released from oxygen support for more than 10 minutes; 8. Clear consciousness, good cognitive function, no previous mental illness or quadriplegia.

Exclusion criteria

Exclusion criteria: 1. Combined with other pulmonary function diseases, such as tuberculosis, lung tumor, etc.; 2. Those with allergic constitution; those with incomplete clinical data; 3. Cerebral embolism caused by rheumatic heart disease, severe coronary heart disease and other serious heart disease combined with atrial fibrillation; 4. Patients with liver and kidney dysfunction, severe infection, severe diabetes, tumor and other diseases; 5. The patient has a history of abdominal surgery, abdominal mass, aneurysm; 6. Scores cannot be calculated due to missing data.

Design outcomes

Primary

MeasureTime frame
maximal voluntary ventilation, MVV;White blood cell count;C reactive protein (CRP);

Countries

China

Contacts

Public ContactTao Yongjun

Lishui Traditional Chinese Medicine Hospital

694287171@qq.com+86 13587198612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026